At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 34 enrolled
Drug / intervention
Placebo Tablet +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Grant to Examine the Feasibility, Efficacy and Tolerability of a Standardized Chamomile Extract in Treating Chronic Primary Insomnia
In Brief
A Phase 2 clinical trial evaluating Chamomile High Grade Extract and Placebo Tablet for Primary Insomnia and Chronic Insomnia. Completed, enrolled 34 participants across 1 site.
Detailed Summary
The purpose of this study is to determine if an herb called chamomile can help to treat insomnia (difficulty in going to sleep or getting enough sleep) by increasing the amount of time that you sleep and/or improving the quality of your sleep. The study will also be looking at the effect of chamomile on day time fatigue and functioning.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPrimary Insomnia, Chronic Insomnia
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJul 2008
Primary CompletionDec 2010
First PostedJan 2011
TodayJul 2026
First PostedJan 31, 2011
Enrollment StartJul 1, 2008
Primary CompletionDec 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 15.4 years ago
Interventions
Chamomile High Grade Extractdietary
three tablets each (equivalent to 7.5 g of dried herb) p.o. twice daily for 28 days
Placebo Tabletdrug